Biosimilars Sponsors Seek Changes In US FDA Guidance On Comparative Analytical Assessments

Childrens building blocks similar to legos, yellow red and blue - Image
Industry takes issue with some of the FDA's recommendations on how to go about demonstrating analytical similarity across products. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Biosimilars

More from Biosimilars & Generics